Cysteamine Bitartrate Patent Expiration

Cysteamine Bitartrate is Used for treating nephropathic cystinosis. It was first introduced by Mylan Pharmaceuticals Inc in its drug Cystagon on Aug 15, 1994. Another drug containing Cysteamine Bitartrate is Procysbi. 2 different companies have introduced drugs containing Cysteamine Bitartrate.


Cysteamine Bitartrate Patents

Given below is the list of patents protecting Cysteamine Bitartrate, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Procysbi US10143665 Methods for storing cysteamine formulations and related methods of treatment Aug 16, 2036 Horizon
Procysbi US10143665

(Pediatric)

Methods for storing cysteamine formulations and related methods of treatment Feb 16, 2037 Horizon
Procysbi US10328037 Methods for storing cysteamine formulations and related methods of treatment Aug 16, 2036 Horizon
Procysbi US10328037

(Pediatric)

Methods for storing cysteamine formulations and related methods of treatment Feb 16, 2037 Horizon
Procysbi US10548859 Methods for storing Cysteamine formulations and related methods of treatment Aug 16, 2036 Horizon
Procysbi US10548859

(Pediatric)

Methods for storing Cysteamine formulations and related methods of treatment Feb 16, 2037 Horizon
Procysbi US10905662 Methods for storing cysteamine formulations and related methods of treatment Aug 16, 2036 Horizon
Procysbi US10905662

(Pediatric)

Methods for storing cysteamine formulations and related methods of treatment Feb 16, 2037 Horizon
Procysbi US8026284 Enterically coated cystamine, cysteamine and derivatives thereof Sep 22, 2027 Horizon
Procysbi US8026284

(Pediatric)

Enterically coated cystamine, cysteamine and derivatives thereof Mar 22, 2028 Horizon
Procysbi US8129433 Enterically coated cysteamine, cystamine and derivatives thereof Jan 26, 2027 Horizon
Procysbi US9173851 Delayed release cysteamine bead formulation, and methods of making and using same Jun 17, 2034 Horizon
Procysbi US9173851

(Pediatric)

Delayed release cysteamine bead formulation, and methods of making and using same Dec 17, 2034 Horizon
Procysbi US9192590 Enterically coated cysteamine, cystamine and derivatives thereof Jan 26, 2027 Horizon
Procysbi US9192590

(Pediatric)

Enterically coated cysteamine, cystamine and derivatives thereof Jul 26, 2027 Horizon
Procysbi US9198882 Enterically coated cysteamine, cystamine and derivatives thereof Jan 26, 2027 Horizon
Procysbi US9198882

(Pediatric)

Enterically coated cysteamine, cystamine and derivatives thereof Jul 26, 2027 Horizon
Procysbi US9233077 Delayed release cysteamine bead formulation, and methods of making and using same Jun 17, 2034 Horizon
Procysbi US9233077

(Pediatric)

Delayed release cysteamine bead formulation, and methods of making and using same Dec 17, 2034 Horizon
Procysbi US9925156 Enterically coated cysteamine, cystamine and derivatives thereof Jan 26, 2027 Horizon
Procysbi US9925156 Enterically coated cysteamine, cystamine and derivatives thereof Jan 26, 2027 Horizon
Procysbi US9925156

(Pediatric)

Enterically coated cysteamine, cystamine and derivatives thereof Jul 26, 2027 Horizon
Procysbi US9925157 Enterically coated cysteamine, cystamine and derivatives thereof Jan 26, 2027 Horizon
Procysbi US9925157 Enterically coated cysteamine, cystamine and derivatives thereof Jan 26, 2027 Horizon
Procysbi US9925157

(Pediatric)

Enterically coated cysteamine, cystamine and derivatives thereof Jul 26, 2027 Horizon
Procysbi US9925158 Enterically coated cysteamine, cystamine and derivatives thereof Jan 26, 2027 Horizon
Procysbi US9925158 Enterically coated cysteamine, cystamine and derivatives thereof Jan 26, 2027 Horizon
Procysbi US9925158

(Pediatric)

Enterically coated cysteamine, cystamine and derivatives thereof Jul 26, 2027 Horizon


Coming Soon

Patent Strength Analyzer

Will this be useful for you?

YesNo

Thank you for your response 🥳